Literature DB >> 19918293

Primary malignant pericardial mesothelioma - a rare cause of pericardial effusion and consecutive constrictive pericarditis: a case report.

Thomas Butz, Lothar Faber, Christoph Langer, Jan Körfer, Oliver Lindner, Andrea Tannapfel, Klaus-Michael Müller, Axel Meissner, Gunnar Plehn, Hans-Joachim Trappe, Dieter Horstkotte, Cornelia Piper.   

Abstract

INTRODUCTION: Primary malignant pericardial mesothelioma is a very rare pericardial tumor of unknown etiology. CASE
PRESENTATION: A 61-year-old Caucasian woman was admitted to our hospital complaining of exertional dyspnea due to a large pericardial effusion. Intrapericardial fluid volume declined after repeated pericardiocentesis, but the patient progressively developed a hemodynamically relevant pericardial constriction. Pericardiectomy revealed a pericardial mesothelioma. Subsequently, four cycles of chemotherapy (dosage according to recently published trials) were administered. The patient remained asymptomatic, and there was no recurrence of the tumor after three years.
CONCLUSION: Pericardial mesothelioma should be considered and managed appropriately in non-responders to pericardiocentesis, and in patients who develop constrictive pericarditis late in their clinical course.

Entities:  

Year:  2009        PMID: 19918293      PMCID: PMC2767155          DOI: 10.4076/1752-1947-3-9256

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


Introduction

Primary malignant pericardial mesothelioma is a very rare pericardial tumor of unknown etiology.

Case presentation

A 61-year-old Caucasian woman was admitted to our hospital complaining of exertional dyspnea (NYHA III) and chest pain. Transthoracic echocardiography demonstrated a large pericardial effusion. Pericardiocentesis revealed 1500 ml of an acellular, sterile pericardial effusion and symptoms were markedly relieved. The patient was re-admitted three months later, and transthoracic echocardiography showed a recurrent large pericardial effusion with partly organized fibrinous structures inside the effusion. There were no signs of cardiac tamponade, but there was a thickened right ventricular pericardium (Figure 1,SD1 and SD2). Magnetic resonance imaging (MRI) confirmed the pericardial effusion, and the slightly thickened pericardium (Figure 2,SD3 and SD4).
Figure 1

Transthoracic echocardiography (apical 4-chamber view) demonstrating a large pericardial effusion and a thickened pericardium of the free wall of the right ventricle (see SD1 and SD2).

Figure 2

Magnetic resonance imaging (4-chamber view, turbo field echo [TFE]) confirmed the extended pericardial effusion without signs of cardiac tamponade, and a slightly thickened pericardium (see SD3 and SD4).

Transthoracic echocardiography (apical 4-chamber view) demonstrating a large pericardial effusion and a thickened pericardium of the free wall of the right ventricle (see SD1 and SD2). Magnetic resonance imaging (4-chamber view, turbo field echo [TFE]) confirmed the extended pericardial effusion without signs of cardiac tamponade, and a slightly thickened pericardium (see SD3 and SD4). An F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) scan demonstrated an intrapericardial accumulation of the tracer, indicating a local infection or a tumor (Figure 3) [1].
Figure 3

F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) scan demonstrating an intrapericardial accumulation of the tracer (Siemens ECAT HR+).

F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) scan demonstrating an intrapericardial accumulation of the tracer (Siemens ECAT HR+). The patient's level of intrapericardial fluid declined after repeated pericardiocentesis, and cytology of the pericardial fluid revealed signs of chronic infection, but no malignant mesothelial cells. Subsequently, the patient developed a hemodynamically relevant pericardial constriction (SD5). Therefore, a partial pericardiectomy was performed, and histological examination (Figures 4a and 4b) revealed a primary malignant pericardial mesothelioma (PMPM). This finding initiated additional subtotal pericardiectomy with resection of as much pericardium as possible. The inspection of the epicardium by the surgeon showed a pericardial thickness of 10 mm and a white-colored spot of the pericardium at the right ventricle. There was no indication of tumor spread to adjacent structures, and there was no tumor on the epicardial site.
Figure 4

Histological examination revealed diffuse infiltration of the pericardium by epithelioid cells due to the primary malignant pericardial mesothelioma (.

Histological examination revealed diffuse infiltration of the pericardium by epithelioid cells due to the primary malignant pericardial mesothelioma (. This was considered to be a PMPM because no signs of a pleural mesothelioma were found. Despite the above-mentioned findings of the magnetic resonance imaging (MRI) scan of the chest, FDG-PET, echocardiography and pericardiocentesis, we suspected PMPM but could not definitively declare a preoperative diagnosis of PMPM. Subsequently, four cycles of chemotherapy with pemetrexed and cisplatin (four cycles in four months - dosage according to recently published trials) were administered, and remission was achieved [2]-[5]. The patient remained asymptomatic, and there was no recurrence of the tumor during the next three years.

Discussion

Diagnosis of pericardial diseases can be challenging and often requires a multimodal imaging approach including echocardiography, MRI, CT and FDG-PET scans [6,7]. The majority of reported pericardial tumors are metastatic in nature and indicate a poor prognosis. Primary tumors of the pericardium are extremely rare, and PMPM is a very rare pericardial tumor of unknown etiology [8]-[10]. So far, about 350 cases have been reported in the literature, and in an epidemiological survey, the annual incidence of PMPM was reported to be one in 40 million (incidence 0.0022%). PMPM is characterized by atypical solid growth of the mesothelium with formation of atypical cavities surrounded by fibrous stroma. There is some recent evidence that asbestos may have a harmful effect on pericardial serosa. However, there has not yet been any definite proven association between asbestos exposure and pericardial disease [2,8]-[10]. Interestingly, our patient had a history of asbestos exposure at work (she worked in a school building). PMPM is often discovered late during a patient's clinical course or at autopsy. Frequent clinical diagnoses refer mainly to acute pericarditis, constrictive pericarditis, and cardiac tamponade and sometimes to various types of coronary heart disease. Surgical resection remains the main treatment modality in PMPM. The prognosis of this disease remains extremely poor due to its late presentation, inability of complete tumor eradication by surgery and the poor response of PMPM to radiotherapy or chemotherapy. A median survival time from the onset of symptoms is six months [8]-[10]. Recently, newer chemotherapeutic regimens after complete excision of the tumor have shown prolonged survival times [2]-[5].

Conclusion

PMPM should be considered and managed appropriately in non-responders to pericardiocentesis or pericardial window for treatment of pericardial effusion or tamponade, and in patients who develop constrictive pericarditis late in their clinical course.

Abbreviations

CT: computer tomography; FDG: 2-fluoro-2-deoxy-d-glucose; FDG-PET: F-18 fluorodeoxyglucose positron emission tomography; MRI: magnetic resonance imaging; PMPM: primary malignant pericardial mesothelioma.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

TB, LF, CL, AM, GP, HJT, DH and CP analyzed and interpreted the patient data regarding the cardiologic disease, therapy and the echocardiographic diagnostic. TB was a major contributor in writing the manuscript. JK analyzed and interpreted the magnetic resonance imaging; OL analyzed and interpreted the FDG-PET. AT and KMM performed the histological examination of the tumor. All authors read and approved the final manuscript.

Supplementary Files

Movie 1 in 1. Transthoracic echocardiography demonstrated the recurrence of a large pericardial effusion and a thickened pericardium in the area of the right ventricle. Movie 2 in 2. Transthoracic echocardiography (subcostal view) demonstrating a pericardial effusion and a markedly thickened pericardium. Movie 3 in 3. Magnetic resonance imaging (MRI) confirmed the extended pericardial effusion without signs of cardiac tamponade, and a slightly thickened pericardium. Movie 4 in 4. Magnetic resonance imaging (MRI) confirmed the extended pericardial effusion without signs of cardiac tamponade, and a slightly thickened pericardium. Movie 5 in 5. Transthoracic echocardiography (subcostal view) demonstrating a markedly thickened pericardium and partly organised, fibrinous structures in the effusion. Click here for file Click here for file Click here for file Click here for file Click here for file
  10 in total

1.  Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology.

Authors:  Bernhard Maisch; Petar M Seferović; Arsen D Ristić; Raimund Erbel; Reiner Rienmüller; Yehuda Adler; Witold Z Tomkowski; Gaetano Thiene; Magdi H Yacoub
Journal:  Eur Heart J       Date:  2004-04       Impact factor: 29.983

2.  Multimodality in imaging calcific constrictive pericarditis.

Authors:  C Langer; T Butz; D Horstkotte
Journal:  Heart       Date:  2006-09       Impact factor: 5.994

3.  Primary pericardial mesothelioma presenting as constrictive pericarditis.

Authors:  G Oreopoulos; L Mickleborough; L Daniel; M De Sa; N Merchant; J Butany
Journal:  Can J Cardiol       Date:  1999-12       Impact factor: 5.223

4.  Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.

Authors:  Pasi A Jänne; Anoinette J Wozniak; Chandra P Belani; Mary-Louise Keohan; Helen J Ross; Jonathan A Polikoff; David M Mintzer; Loretta Taylor; Joseph Ashland; Zhishen Ye; Matthew J Monberg; Coleman K Obasaju
Journal:  Clin Lung Cancer       Date:  2005-07       Impact factor: 4.785

5.  F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report.

Authors:  Piet Ost; Sylvie Rottey; Peter Smeets; Tom Boterberg; Barbara Stragier; Ingeborg Goethals
Journal:  J Thorac Imaging       Date:  2008-02       Impact factor: 3.000

6.  Triplet chemotherapy for malignant pericardial mesothelioma: a case report.

Authors:  Riichiroh Maruyama; Maki Sakai; Tomomi Nakamura; Ryuichi Suemitsu; Tatsuro Okamoto; Hiroshi Wataya; Kenichi Nishiyama; Toshiaki Kamei; Yukito Ichinose
Journal:  Jpn J Clin Oncol       Date:  2006-03-13       Impact factor: 3.019

Review 7.  Pericardial tumors.

Authors:  Adriana Luk; Eric Ahn; Pradeep Vaideeswar; Jagdish W Butany
Journal:  Semin Diagn Pathol       Date:  2008-02       Impact factor: 3.464

8.  Primary pericardial mesothelioma presenting as pericardial constriction: a case report.

Authors:  S Suman; P Schofield; S Large
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

9.  Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program.

Authors:  Paul Taylor; Bruno Castagneto; Graham Dark; Maurizio Marangolo; Giorgio V Scagliotti; Rob J van Klaveren; Roberto Labianca; Monika Serke; W Schuette; Jan P van Meerbeeck; David Heigener; Yushan Liu; Susumu Adachi; Johannes Blatter; Joachim von Pawel
Journal:  J Thorac Oncol       Date:  2008-07       Impact factor: 15.609

10.  Primary pericardial mesothelioma.

Authors:  Cristina Santos; Jesus Montesinos; Eva Castañer; Josep Maria Sole; Rosa Baga
Journal:  Lung Cancer       Date:  2007-10-23       Impact factor: 5.705

  10 in total
  13 in total

1.  A rare cause of heart failure with preserved ejection fraction: primary pericardial mesothelioma masquerading as pericardial constriction.

Authors:  Russell Fernandes; Shravan Nosib; Dorothy Thomson; Nick Baniak
Journal:  BMJ Case Rep       Date:  2014-03-20

2.  Three-year survival after surgery for primary malignant pericardial mesothelioma: report of a case.

Authors:  Kishu Fujita; Mitsumasa Hata; Akira Sezai; Kazutomo Minami
Journal:  Surg Today       Date:  2013-02-14       Impact factor: 2.549

3.  Malignant pericardial mesothelioma : A systematic review of current practice.

Authors:  S Cao; S Jin; J Cao; J Shen; H Zhang; Q Meng; B Pan; Y Yu
Journal:  Herz       Date:  2017-01-27       Impact factor: 1.443

Review 4.  MRI assessment of cardiac tumours: part 2, spectrum of appearances of histologically malignant lesions and tumour mimics.

Authors:  Edward T D Hoey; Muhammad Shahid; Arul Ganeshan; Shobhit Baijal; Helen Simpson; Richard W Watkin
Journal:  Quant Imaging Med Surg       Date:  2014-12

5.  Primary malignant pericardial mesothelioma-a rare cause of superior vena cava thrombosis and constrictive pericarditis.

Authors:  Wenhui Gong; Xiaofeng Ye; Kaihu Shi; Qiang Zhao
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

6.  Positive response of a primary malignant pericardial mesothelioma to pemetrexed plus cisplatin followed by pemetrexed maintenance chemotherapy: A case report.

Authors:  Sang Mi Chung; Seong Ji Choi; Min Jung Kim; Jung Yoon Choi; Hong Jun Kim; Suk-Young Lee; Eun Joo Kang
Journal:  Oncol Lett       Date:  2016-05-17       Impact factor: 2.967

7.  A case report of an extremely rare and aggressive tumor: primary malignant pericardial mesothelioma.

Authors:  Xiaolan Feng; Liena Zhao; Guangming Han; Moosa Khalil; Francis Green; Travis Ogilvie; Vanessa Krause
Journal:  Rare Tumors       Date:  2012-04-13

8.  A rare case of primary malignant pericardial mesothelioma.

Authors:  Rajoo Ramachandran; Prabhu Radhan; Roy Santosham; Swaminathan Rajendiran
Journal:  J Clin Imaging Sci       Date:  2014-08-30

9.  18F-fluorodeoxyglucose imaging of primary malignant pericardial mesothelioma with concurrent pericardial and pleural effusions and bone metastasis: A case report.

Authors:  Xiaohui Li; Rugang Lu; Youcai Zhao; Feng Wang; Guoqiang Shao
Journal:  Mol Clin Oncol       Date:  2018-04-12

10.  Primary pericardial mesothelioma: a rare entity.

Authors:  Mohit Godar; Jianhua Liu; Pengguo Zhang; Yang Xia; Qinghai Yuan
Journal:  Case Rep Oncol Med       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.